12/15-Lipoxygenase Inhibition Counteracts MAPK Phosphorylation in Mouse and Cell Culture Models of Diabetic Peripheral Neuropathy

Journal of Diabetes Mellitus
doi 10.4236/jdm.2013.33015
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Scientific Research Publishing, Inc,

Related search

Poly(ADP-Ribose)polymerase Inhibition Counteracts Renal Hypertrophy and Multiple Manifestations of Peripheral Neuropathy in Diabetic Akita Mice

International Journal of Molecular Medicine
MedicineGenetics
2011English

5-Lipoxygenase, but Not 12/15-Lipoxygenase, Contributes to Degeneration of Retinal Capillaries in a Mouse Model of Diabetic Retinopathy

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2008English

Inhibition of 12/15-Lipoxygenase as Therapeutic Strategy to Treat Stroke

Annals of Neurology
Neurology
2012English

Beneficial Effect of TNF-α Inhibition on Diabetic Peripheral Neuropathy

Journal of Neuroinflammation
Molecular NeuroscienceNeurologyImmunologyCellularNeuroscience
2013English

Criteria for Creating and Assessing Mouse Models of Diabetic Neuropathy

Current Drug Targets
Molecular MedicineDrug DiscoveryClinical BiochemistryPharmacology
2008English

Role of 12/15-Lipoxygenase in the Expression of McP-1 in Mouse Macrophages

American Journal of Physiology - Heart and Circulatory Physiology
Cardiovascular MedicinePhysiologyCardiology
2008English

Peripheral Nerve Conduction in Diabetic Neuropathy

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1962English

Targeting Molecular Chaperones in Diabetic Peripheral Neuropathy

2012English

A Peroxynitrite Decomposition Catalyst Counteracts Sensory Neuropathy in Streptozotocin-Diabetic Mice

European Journal of Pharmacology
Pharmacology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy